|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 5:7–30. 2015.
|
|
2
|
Huang Z, Huang D, Ni S, Peng Z, Sheng W
and Du X: Plasma microRNAs are promising novel biomarkers for early
detection of colorectal cancer. Int J Cancer. 127:118–126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Terzić J, Grivennikov S, Karin E and Karin
M: Inflammation and colon cancer. Gastroenterology. 138(2101–2114):
e52010.
|
|
4
|
Buunen M, Veldkamp R, Hop WC, Kuhry E,
Jeekel J, Haglind E, Påhlman L, Cuesta MA, Msika S, Morino M, et
al: Colon Cancer Laparoscopic or Open Resection Study Group:
Survival after laparoscopic surgery versus open surgery for colon
cancer: Long-term outcome of a randomised clinical trial. Lancet
Oncol. 10:44–52. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen Z, Zhan G, Ye D, Ren Y, Cheng L, Wu Z
and Guo J: MicroRNA-34a affects the occurrence of laryngeal
squamous cell carcinoma by targeting the antiapoptotic gene
survivin. Med Oncol. 29:2473–2480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xiao CZ, Wei W, Guo ZX, Zhang MY, Zhang
YF, Wang JH, Shi M, Wang HY and Guo RP: MicroRNA-34c-3p promotes
cell proliferation and invasion in hepatocellular carcinoma by
regulation of NCKAP1 expression. J Cancer Res Clin Oncol.
143:263–273. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fattore L, Sacconi A, Mancini R and
Ciliberto G: MicroRNA-driven deregulation of cytokine expression
helps development of drug resistance in metastatic melanoma.
Cytokine Growth Factor Rev. 36:39–48. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Douaiher J, Ravipati A, Grams B, Chowdhury
S, Alatise O and Are C: Colorectal cancer-global burden, trends,
and geographical variations. J Surg Oncol. 115:619–630. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Munteanu CR, Magalhães AL, Uriarte E and
González-Díaz H: Multi-target QPDR classification model for human
breast and colon cancer-related proteins using star graph
topological indices. J Theor Biol. 257:303–311. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Inui M, Martello G and Piccolo S: MicroRNA
control of signal transduction. Nat Rev Mol Cell Biol. 11:252–263.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheng H, Zhang L, Cogdell DE, Zheng H,
Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR and Zhang W:
Circulating plasma MiR-141 is a novel biomarker for metastatic
colon cancer and predicts poor prognosis. PLoS One. 6:e177452011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu Y, Nangia-Makker P, Farhana L, Rajendra
SG, Levi E and Majumdar AP: miR-21 and miR-145 cooperation in
regulation of colon cancer stem cells. Mol Cancer. 14:982015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cekaite L, Rantala JK, Bruun J, Guriby M,
Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe
RA, et al: MiR-9, −31, and −182 deregulation promote proliferation
and tumor cell survival in colon cancer. Neoplasia. 14:868–879.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Karaayvaz M, Pal T, Song B, Zhang C,
Georgakopoulos P, Mehmood S, Burke S, Shroyer K and Ju J:
Prognostic significance of miR-215 in colon cancer. Clin Colorectal
Cancer. 10:340–347. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de Carvalho AC, Scapulatempo-Neto C, Maia
DC, Evangelista AF, Morini MA, Carvalho AL and Vettore AL: Accuracy
of microRNAs as markers for the detection of neck lymph node
metastases in patients with head and neck squamous cell carcinoma.
BMC Med. 13:1082015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ruiz AJ and Russell SJ: MicroRNAs and
oncolytic viruses. Curr Opin Virol. 13:40–48. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Lin C, Liao G, Liu S, Ding J,
Tang F, Wang Z, Liang X, Li B, Wei Y, et al: MicroRNA-506
suppresses tumor proliferation and metastasis in colon cancer by
directly targeting the oncogene EZH2. Oncotarget. 6:32586–32601.
2015.PubMed/NCBI
|
|
21
|
Tölle A, Jung M, Rabenhorst S, Kilic E,
Jung K and Weikert S: Identification of microRNAs in blood and
urine as tumour markers for the detection of urinary bladder
cancer. Oncol Rep. 30:1949–1956. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Agaoglu Yaman F, Kovancilar M, Dizdar Y,
Darendeliler E, Holdenrieder S, Dalay N and Gezer U: Investigation
of miR-21, miR-141, and miR-221 in blood circulation of patients
with prostate cancer. Tumour Biol. 32:583–588. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schwarzenbach H, Milde-Langosch K,
Steinbach B, Müller V and Pantel K: Diagnostic potential of
PTEN-targeting miR-214 in the blood of breast cancer patients.
Breast Cancer Res Treat. 134:933–941. 2012. View Article : Google Scholar : PubMed/NCBI
|
